Fyodor Biotechnologies
500 Global GA 22 · Developer of a non-invasive malaria testing technology designed to deliver a simple system to major global health problems.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Not stated | 500 Global2012 | |
| Other | Not stated | 500 GlobalGA 22 | |
| Other | Not stated | EF2020 | |
| Other | Not stated | EF2024 | |
| Other | Not stated | Plug and Play |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Tunable BiosystemsShared: non invasive, health tech, developerNot statedOther | Other | Not stated | 500 Global2025 |
| Other | Not stated | EF2024 | |
| Other | Not stated | Plug and Play | |
| Other | Active | YCS18 | |
| AI | Active | YCS17 |
Also from 500 Global GA 22
All of 500 Global GA 22Programs
| Program | Cohort | Source |
|---|---|---|
| GA 22 · 2018 | 500 Global Page |
About Fyodor Biotechnologies
Developer of a non-invasive malaria testing technology designed to deliver a simple system to major global health problems. The company's technology helps people with a fever to diagnose malaria using a few drops of urine instead of blood, enabling healthcare professionals to help patients diagnose malaria conveniently and minimize pain and blood loss.
- Category
- Other
- Location
- United States
- Checked
- 2h ago
Tags: Health Tech
Fyodor Biotechnologies: questions
Which accelerators did Fyodor Biotechnologies go through?
Fyodor Biotechnologies is listed by 500 Global (Global GA 22).
Where is Fyodor Biotechnologies based?
Fyodor Biotechnologies lists United States as its location on 500 Global's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.